Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,821 | 271 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,051 | 100 | $0 (2024) |
| Novo Nordisk Inc | $532.43 | 31 | $0 (2024) |
| ABBVIE INC. | $531.29 | 36 | $0 (2024) |
| GlaxoSmithKline, LLC. | $295.35 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $251.63 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $107.45 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $104.90 | 8 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $100.12 | 7 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $98.58 | 7 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $79.47 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $745.84 | 57 | PFIZER INC. ($240.54) |
| 2023 | $773.89 | 59 | PFIZER INC. ($244.76) |
| 2022 | $564.51 | 37 | Novo Nordisk Inc ($164.57) |
| 2021 | $589.47 | 43 | PFIZER INC. ($264.42) |
| 2020 | $187.18 | 13 | PFIZER INC. ($52.82) |
| 2019 | $328.66 | 20 | AbbVie, Inc. ($43.58) |
| 2018 | $362.69 | 24 | PFIZER INC. ($63.65) |
| 2017 | $268.85 | 18 | GlaxoSmithKline, LLC. ($65.24) |
All Payment Transactions
271 individual payment records from CMS Open Payments — Page 3 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: VACCINES | ||||||
| 02/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: VACCINES | ||||||
| 02/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.15 | General |
| Category: Narcoplepsy | ||||||
| 01/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: VACCINES | ||||||
| 01/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $1.26 | General |
| Category: VACCINES | ||||||
| 12/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Biological | ||||||
| 12/06/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: VACCINES | ||||||
| 11/21/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $3.69 | General |
| Category: VACCINES | ||||||
| 11/20/2023 | PFIZER INC. | COMIRNATY (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: VACCINES | ||||||
| 11/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Obesity | ||||||
| 11/08/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2023 | PFIZER INC. | COMIRNATY (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: VACCINES | ||||||
| 10/19/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: VACCINES | ||||||
| 10/19/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: VACCINES | ||||||
| 10/10/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: VACCINES | ||||||
| 10/04/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Biological | ||||||
| 09/28/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: VACCINES | ||||||
| 09/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 09/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,865 | 2,217 | $283,313 | $221,081 |
| 2022 | 24 | 1,567 | 1,878 | $220,907 | $164,874 |
| 2021 | 24 | 1,651 | 2,148 | $255,530 | $190,375 |
| 2020 | 21 | 1,577 | 2,052 | $219,420 | $160,728 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 101 | $13,433 | $8,795 | 65.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 44 | 51 | $7,344 | $4,552 | 62.0% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 28 | 30 | $6,600 | $4,417 | 66.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 23 | 23 | $4,370 | $4,161 | 95.2% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 19 | 21 | $4,725 | $3,793 | 80.3% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 14 | 14 | $3,480 | $3,379 | 97.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 183 | 185 | $5,550 | $3,367 | 60.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 44 | $4,840 | $3,249 | 67.1% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 12 | 12 | $3,720 | $2,900 | 78.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 15 | 15 | $2,850 | $2,719 | 95.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 15 | 36 | $2,880 | $2,124 | 73.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 45 | 50 | $4,500 | $2,112 | 46.9% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 15 | 17 | $2,635 | $1,873 | 71.1% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 16 | 17 | $1,215 | $1,100 | 90.5% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 13 | 14 | $1,050 | $586.04 | 55.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 45 | 46 | $2,300 | $570.24 | 24.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 23 | 23 | $690.00 | $418.16 | 60.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 62 | 64 | $1,088 | $192.00 | 17.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 266 | 447 | $55,955 | $37,060 | 66.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 255 | 255 | $33,210 | $32,045 | 96.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 128 | 276 | $25,116 | $17,246 | 68.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 186 | 190 | $12,300 | $11,464 | 93.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 55 | 62 | $13,980 | $10,733 | 76.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 23 | 100 | $13,300 | $9,002 | 67.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 74 | 76 | $13,452 | $8,848 | 65.8% |
About Dr. David Litt, MD
Dr. David Litt, MD is a Internal Medicine healthcare provider based in Meadowbrook, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265403240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Litt, MD has received a total of $3,821 in payments from pharmaceutical and medical device companies, with $745.84 received in 2024. These payments were reported across 271 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,821).
As a Medicare-enrolled provider, Litt has provided services to 6,660 Medicare beneficiaries, totaling 8,295 services with total Medicare billing of $737,058. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Meadowbrook, PA
- Active Since 01/30/2006
- Last Updated 07/18/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265403240
Products in Payments
- ELIQUIS (Drug) $673.80
- PREVNAR 20 (Biological) $266.90
- Ozempic (Drug) $209.87
- Rybelsus (Drug) $204.02
- UBRELVY (Drug) $197.50
- TRELEGY ELLIPTA (Drug) $180.58
- VRAYLAR (Drug) $148.07
- CHANTIX (Drug) $116.40
- ANORO (Drug) $102.05
- QULIPTA (Drug) $100.79
- XARELTO (Drug) $100.12
- MYRBETRIQ (Drug) $85.65
- Creon (Drug) $84.93
- XIFAXAN (Drug) $78.32
- Veozah (Drug) $70.08
- Cologuard Collection Kit (Device) $63.35
- Myrbetriq (Drug) $60.79
- ENTRESTO (Drug) $56.49
- TRUMENBA (Biological) $44.13
- NUEDEXTA (Drug) $42.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Meadowbrook
John Butler, Md, MD
Internal Medicine — Payments: $2,871
Dominick Galluzzo, Md, MD
Internal Medicine — Payments: $2,072
Dr. Leonard Khrizman, M.d, M.D
Internal Medicine — Payments: $551.55
Joseph Viknevich, M.d, M.D
Internal Medicine — Payments: $453.22
Dr. Babak Pirouz, Md, MD
Internal Medicine — Payments: $314.45
Maureen Armstrong, Do, DO
Internal Medicine — Payments: $121.36